NCT Number: NCT00113178
Safety and Efficacy of the CryoCor™ Cardiac Cryoablation System for the Treatment of Atrial Flutter
The purpose of this study is to evaluate the safety and efficacy of right atrial intra-cardiac lesions created by transvenous catheter cryoablation in patients with atrial flutter.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–75 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 3
About this study
Catheter ablation of arrhythmias has become an accepted alternative to pharmacologic therapy. Cryoablation is a newer alternative to radiofrequency ablations. This study expands the prior pilot experience with the CryoCor™ Cardiac Cryoablation System to a larger cohort of patients with atrial flutter.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Symptomatic atrial flutter
Exclusion criteria
- Prior ablation
- Contraindication to intervention
- Poor general health
Treatment and study plan
Primary outcomes
-
Acute efficacy
-
Acute safety
Secondary outcomes
-
Long-term efficacy
-
Long-term safety
Sponsors and collaborators
Lead sponsor
Boston Scientific Corporation
Industry
Registry information
Official study title
Clinical Study to Evaluate the Safety and Efficacy of the CryoCor™ Cardiac Cryoablation System for the Treatment of Cavo-Tricuspid Valve Isthmus-Dependent Atrial Flutter
Important dates
- Study start
- 2004
- Study completion
- 2005
- First posted
- Jun 7, 2005
- Registry last updated
- Feb 24, 2011
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Impact of Catheter Ablation on ABC Risk Scores
NCT05635864
Arrhythmias, Cardiac, Atrial Fibrillation
Hanover, Lower Saxony, Germany
View Trial DetailsArrhythmias in Post-Myocardial Infarction Patients
NCT03231826
Arrhythmias, Cardiac, Arrythmia
Tampere, Pirkanmaa, Finland
View Trial DetailsProspective Observational Cohort Study of Fetal Atrial Flutter & Supraventricular Tachycardia
NCT03376438
Arrhythmias, Cardiac, Atrial Flutter
Phoenix, Arizona, United States
View Trial DetailsAn Initial Assessment of the Sphere-9™ Catheter and Affera Mapping and Ablation System
NCT04210622
Arrhythmias, Cardiac, Atrial Fibrillation
Vilnius, Lithuania
View Trial Details